EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Efficacy and safety of henagliflozin in IgA nephropathy: A real-world observational study from China

Yi Qian Zhang, Jun Xia Wu, Hai Yan Tu, Zhao Ting Ren, Pei Pei Chen, Jia Xiu Zhang, Kun Ling Ma

Clinical Nephrology · 2026

DOI: 10.5414/cn111956 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Nephrology, 2026. Verfasst von Yi Qian Zhang und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Sodium-Glucose Transporter 2 Inhibitors, Glucosides, Kidney.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, IGASodium-Glucose Transporter 2 InhibitorsGlucosidesKidneyBenzhydryl CompoundsHumansFemaleMaleRetrospective StudiesChinaGlomerular Filtration RateAdultTreatment OutcomeMiddle AgedCreatinineAlbuminuriaUric Acid

Substanzen

Sodium-Glucose Transporter 2 InhibitorsCreatinineUric AcidGlucosidesBenzhydryl Compounds

Zitieren

APA

Zhang, Y. Q., Wu, J. X., Tu, H. Y., Ren, Z. T., Chen, P. P., Zhang, J. X., & Ma, K. L. (2026). Efficacy and safety of henagliflozin in IgA nephropathy: A real-world observational study from China. Clinical Nephrology. https://doi.org/10.5414/cn111956

Vancouver

Zhang YQ, Wu JX, Tu HY, Ren ZT, Chen PP, Zhang JX, et al. Efficacy and safety of henagliflozin in IgA nephropathy: A real-world observational study from China. Clinical Nephrology. 2026. doi:10.5414/cn111956

BibTeX
@article{Zhang2026,
  author = {Zhang, Yi Qian and Wu, Jun Xia and Tu, Hai Yan and Ren, Zhao Ting and Chen, Pei Pei and Zhang, Jia Xiu and Ma, Kun Ling},
  title = {Efficacy and safety of henagliflozin in IgA nephropathy: A real-world observational study from China},
  journal = {Clinical Nephrology},
  year = {2026},
  doi = {10.5414/cn111956}
}
Kostenlos starten →